Skip to main content
Log in

Muscle cramps and elevated serum creatine phosphokinase levels induced by β-adrenoceptor blockers

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

We have assessed the propensity of β-adrenoceptor blockers to cause muscle cramps and to raise the serum creatine phosphokinase (CPK) level in 78 patients with essential hypertension. After a control period, a β-adrenoceptor blocker without intrinsic sympathomimetic activity (ISA; propranolol, metoprolol or arotinolol) was administered for three months. Thereafter, the patients were randomised to receive a β-adrenoceptor blocker with ISA (pindolol or carteolol) for three months or a β-adrenoceptor blocker without ISA for a further three months. This pattern was continued until all β-adrenoceptor blockers had been given. At the end of each period, CPK and CPK-MB levels were measured.

Of the 78 subjects, muscle cramps occurred in 27 during treatment with pindolol and 32 during treatment with carteolol. No complaints were made by subjects treated with propranolol and arotinolol, but muscle cramps were reported in 2 treated with metoprolol. While muscle cramps were caused both by pindolol and carteolol in 16 subjects, they were caused by either of these drugs in the remainder of the subjects. Muscle cramp occurred mainly in the calves when the patients were in bed at night. Serum CPK and CPK-MB levels increased significantly during treatment with pindolol (control period vs pindolol, CPK=96 vs 133 IU · ml−1, CPK-MB=14 vs 18 IU · ml−1) or carteolol (CPK=117 IU · ml−1, CPK-MB=18 IU · ml−1) while the levels during treatment with propranolol, arotinolol and metoprolol did not change from those in the control period. The change in serum CPK during treatment with carteolol or pindolol was significantly correlated with the control serum CPK level. No correlation was observed between muscle cramps and serum CPK level. There were individual differences in the severity of muscle cramps, with some subjects complaining frequently of severe muscle cramps.

Because muscle cramps are frequently experienced at night, they disturb sleep and lower the quality of life in patients. This problem should be considered during treatment with β-adrenoceptor blockers with ISA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Herishanu Y, Rosenberg P (1975) β-blockers and myasthenia gravis. Ann Intern Med 83: 834–835

    Google Scholar 

  2. Hughes RO, Zacharias FJ (1976) Myasthenic syndrome during treatment with practolol. Br Med J 1: 460–461

    Google Scholar 

  3. Forfar JC, Brown GJ, Cull RE (1979) Proximal myopathy during beta-blockade. Br Med J 2: 1331–1332

    Google Scholar 

  4. Shaivitz SA (1979) Timolol and myasthenia gravis. JAMA 242: 1611–1612

    Google Scholar 

  5. Teicher A, Rosenthal T, Kissin E, Sarova I (1981) Labetalol-induced toxic myopathy. Br Med J 282: 1824–1825

    Google Scholar 

  6. Imataka K, Seki A, Takahashi N, Fujii J, Ohuchi Y, Kuwako K, Umeda T, Machii K, Hasegawa T, Ozoe A (1981) Elevation of serum creatine phophokinase during pindolol treatment (in Japanese). Jpn J Med 70: 580–585

    Google Scholar 

  7. Anthony M, Lance JW, Somerville B (1972) A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine. Med J Aust 1: 1343–1346

    Google Scholar 

  8. Gonasun LM, Langrall H (1982) Adverse reactions to pindolol administration. Am Heart J 104: 482–486

    Google Scholar 

  9. Greminger P, Vetter H, Boerlin HJ, Havelka J, Baumgart P, Walger P, Lüscher T, Siegenthaler W, Vette W (1983) A comparative study between 100 mg atenolol and 20 mg pindolol slow-release in essential hypertension. Drugs 25 [Suppl 2]: 37–41

    Google Scholar 

  10. Saruta T, Itoh H (1983) Changes of CPK and CPK isozymes on the administration of several β-adrenoceptor blockers (in Japanese). Pharmacol Treat 7: 145–154

    Google Scholar 

  11. Morgan TO, Anevekar SN, Sahto J, Louis WJ, Doyle AE (1974) A comparison of beta-adrenergic blocking drugs in the treatment of hypertension. Postgrad Med J 50: 253–259

    Google Scholar 

  12. Prichard BNC (1978) β-Adrenergic receptor blockade in hypertension, past, present and future. J Clin Pharmacol 379–399

  13. Rosalki SB (1967) An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 69: 696–705

    Google Scholar 

  14. Empfehlungen der Deutschen Gesellschaft für Klinische Chemie (1977) Standard-Methode zur Bestimmung der Aktivität der Kreatin-Kinase. J Clin Chem Clin Biochem 15: 249–254

    Google Scholar 

  15. Wüerzburg U, Hennrich N, Orth HD, Lang H (1977) Quantitative determination of creatine kinase isoenzyme catalytic concentrations in serum using immunological methods. J Clin Chem Clin Biochem 15: 131–137

    Google Scholar 

  16. Larochelle P, Hamet P, Hoffman B, Kuchel O, Mckenzie J, Mitenko P, Ogilvie RI, Rudy J (1980) Labetalol in essential hypertension. J Cardiovasc Pharmacol 2: 751–759

    Google Scholar 

  17. Thomson WHS (1986) Determination and statistical analyses of the normal ranges for five serum enzymes. Clin Chim Acta 21: 469–478

    Google Scholar 

  18. Griffiths PD (1966) Serum levels of ATP: creatine phosphotranspherase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta 13: 413–420

    Google Scholar 

  19. Paterson Y, Lawrence EF (1972) Factors affecting serum creatine phosphokinase levels in normal adult females. Clin Chim Acta 42: 131–139

    Google Scholar 

  20. Marsden CD, Foley TH, Owen DAL, McAllister RG (1967) Peripheral β-adrenergic receptors concerned with tremor. Clin Sci 33: 53–65

    Google Scholar 

  21. Marlin GE, Turner P (1975) Comparison of the β2-adrenoceptor selectivity of rimitelol, salbutamol and isoprenaline by the intravenous route in man. Br J Clin Pharmacol 2: 41–48

    Google Scholar 

  22. Larsson S, Svedmyr N (1977) Tremor caused by sympathomimetics is mediated by beta2-adrenoceptors. Scand J Resp Dis 58: 5–10

    Google Scholar 

  23. Sato S, Ikeda H, Yasui S, Takahashi K (1987) Cramp of voluntary muscles in patients with bronchial asthma treated with beta-receptor stimulants (in Japanese). Kokyu 6: 334–337

    Google Scholar 

  24. Bowman WC, Zaimis E (1958) The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat. J Physiol 144: 92–107

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imai, Y., Watanabe, N., Hashimoto, J. et al. Muscle cramps and elevated serum creatine phosphokinase levels induced by β-adrenoceptor blockers. Eur J Clin Pharmacol 48, 29–34 (1995). https://doi.org/10.1007/BF00202168

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00202168

Key words

Navigation